Birdwatch Archive

Birdwatch Note

2025-03-09 06:19:46 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING

そもそも「ケタペン」という薬剤は存在しない。 フェンタニルは1972年日本に導入されたが、流通・使用は「麻薬及び向精神薬取締法」で厳格に管理されている。 一方、WHOは疼痛管理のためのオピオイド適正使用量指標を定めているが、日本は約75%と、むしろ充分な使用がされていないことが問題となっている。 日本でのオピオイドクライシスを防ぐために https://www.jstage.jst.go.jp/article/jjspc/28/12/28_21-0059/_article/-char/ja/ Prefectural Adequacy of Opioid Availability for Cancer Pain and Its Determinants in Japan https://www.jmaj.jp/detail.php?id=10.31662%2Fjmaj.2020-0037

Written by 002CC6530A91707CBD2863FA9D55197FD120B3CB0E3213F4C4890511FB9E707D
Participant Details

Original Tweet

Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1898303842011287798

Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.

All Information

  • ID - 1898619702022389902
  • noteId - 1898619702022389902
  • participantId -
  • noteAuthorParticipantId - 002CC6530A91707CBD2863FA9D55197FD120B3CB0E3213F4C4890511FB9E707D Participant Details
  • createdAtMillis - 1741501186267
  • tweetId - 1898303842011287798
  • classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
  • believable -
  • harmful -
  • validationDifficulty -
  • misleadingOther - 0
  • misleadingFactualError - 1
  • misleadingManipulatedMedia - 0
  • misleadingOutdatedInformation - 0
  • misleadingMissingImportantContext - 1
  • misleadingUnverifiedClaimAsFact - 1
  • misleadingSatire - 0
  • notMisleadingOther - 0
  • notMisleadingFactuallyCorrect - 0
  • notMisleadingOutdatedButNotWhenWritten - 0
  • notMisleadingClearlySatire - 0
  • notMisleadingPersonalOpinion - 0
  • trustworthySources - 1
  • summary
    • そもそも「ケタペン」という薬剤は存在しない。 フェンタニルは1972年日本に導入されたが、流通・使用は「麻薬及び向精神薬取締法」で厳格に管理されている。 一方、WHOは疼痛管理のためのオピオイド適正使用量指標を定めているが、日本は約75%と、むしろ充分な使用がされていないことが問題となっている。 日本でのオピオイドクライシスを防ぐために https://www.jstage.jst.go.jp/article/jjspc/28/12/28_21-0059/_article/-char/ja/ Prefectural Adequacy of Opioid Availability for Cancer Pain and Its Determinants in Japan https://www.jmaj.jp/detail.php?id=10.31662%2Fjmaj.2020-0037

Note Ratings

rated at rated by
2025-03-10 01:09:09 -0500 Rating Details
2025-03-09 23:18:39 -0500 Rating Details
2025-03-09 22:59:01 -0500 Rating Details
2025-03-09 21:00:24 -0500 Rating Details
2025-03-09 20:34:15 -0500 Rating Details
2025-03-09 20:26:04 -0500 Rating Details
2025-03-09 17:42:13 -0500 Rating Details
2025-03-09 13:25:56 -0500 Rating Details
2025-03-09 12:51:45 -0500 Rating Details
2025-03-09 12:46:38 -0500 Rating Details
2025-03-09 12:39:41 -0500 Rating Details
2025-03-09 10:48:18 -0500 Rating Details
2025-03-09 10:32:09 -0500 Rating Details
2025-03-09 09:57:41 -0500 Rating Details
2025-03-09 09:46:40 -0500 Rating Details
2025-03-09 07:37:37 -0500 Rating Details
2025-03-09 07:20:49 -0500 Rating Details
2025-03-09 07:09:23 -0500 Rating Details
2025-03-09 06:37:07 -0500 Rating Details
2025-03-09 06:18:29 -0500 Rating Details
2025-03-09 05:40:36 -0500 Rating Details
2025-03-09 05:40:35 -0500 Rating Details
2025-03-09 05:24:24 -0500 Rating Details
2025-03-09 05:16:16 -0500 Rating Details
2025-03-09 05:13:50 -0500 Rating Details
2025-03-09 04:47:49 -0500 Rating Details
2025-03-09 04:40:30 -0500 Rating Details
2025-03-09 04:36:21 -0500 Rating Details
2025-03-09 04:29:56 -0500 Rating Details
2025-03-09 04:05:04 -0500 Rating Details
2025-03-09 01:52:13 -0600 Rating Details
2025-03-09 01:46:54 -0600 Rating Details
2025-03-09 01:41:20 -0600 Rating Details
2025-03-09 01:41:08 -0600 Rating Details
2025-03-09 01:27:56 -0600 Rating Details
2025-03-09 01:13:21 -0600 Rating Details
2025-03-09 01:09:52 -0600 Rating Details
2025-03-09 01:08:00 -0600 Rating Details
2025-03-09 00:59:06 -0600 Rating Details
2025-03-09 00:51:41 -0600 Rating Details
2025-03-09 00:45:11 -0600 Rating Details
2025-03-09 00:28:43 -0600 Rating Details
2025-03-12 16:54:00 -0500 Rating Details
2025-03-12 13:39:38 -0500 Rating Details
2025-03-11 02:38:25 -0500 Rating Details
2025-03-11 01:12:05 -0500 Rating Details
2025-03-09 21:38:19 -0500 Rating Details
2025-03-09 21:13:30 -0500 Rating Details
2025-03-09 20:39:49 -0500 Rating Details
2025-03-09 20:23:01 -0500 Rating Details
2025-03-09 19:42:43 -0500 Rating Details
2025-03-09 18:42:39 -0500 Rating Details
2025-03-09 17:18:51 -0500 Rating Details
2025-03-09 15:56:24 -0500 Rating Details
2025-03-09 09:42:31 -0500 Rating Details
2025-03-09 08:22:31 -0500 Rating Details
2025-03-09 08:19:27 -0500 Rating Details
2025-03-09 06:51:00 -0500 Rating Details
2025-03-09 06:31:30 -0500 Rating Details
2025-03-09 05:28:07 -0500 Rating Details
2025-03-09 04:55:58 -0500 Rating Details
2025-03-09 04:49:24 -0500 Rating Details
2025-03-09 04:33:46 -0500 Rating Details
2025-03-09 03:36:14 -0500 Rating Details
2025-03-09 01:51:18 -0600 Rating Details
2025-03-09 01:46:22 -0600 Rating Details
2025-03-09 01:21:16 -0600 Rating Details
2025-03-09 01:05:20 -0600 Rating Details
2025-03-09 00:33:05 -0600 Rating Details
2025-03-09 00:25:53 -0600 Rating Details
2025-03-09 00:22:31 -0600 Rating Details